Changes in methadone maintenance therapy during and after pregnancy

J Subst Abuse Treat. 2011 Dec;41(4):347-53. doi: 10.1016/j.jsat.2011.05.002. Epub 2011 Jul 7.

Abstract

Objective: The aim of this study is to better understand anticipated changes in daily methadone doses as a guide for prescription during pregnancy.

Methods: This retrospective case series involved a single cohort longitudinal design of 139 consecutively chosen women who began methadone therapy before 26 completed gestational weeks. Changes in the single daily dose were based on a standard opiate withdrawal scale and determined from early pregnancy until 6 weeks postpartum.

Results: As gestation advanced, the methadone dose increased (86%) rather than remained the same (8%) or decreased (7%). This gradual increase in daily dose during pregnancy (mean increase = 24 mg, 95% confidence level = 20-28 mg) was statistically significant (p < .001) regardless of the initial maintenance dose. By the sixth postpartum week, most subjects (85%) took within 10 mg of their dose at delivery (mean change in dose = -4 mg, 95% confidence interval = -6 to -2 mg).

Conclusions: Daily doses of methadone increased until the third trimester, then remained essentially unchanged through the sixth postpartum week.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics, Opioid / therapeutic use*
  • Computers
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Inpatients / psychology*
  • Methadone / therapeutic use*
  • Opiate Substitution Treatment / methods*
  • Opiate Substitution Treatment / trends*
  • Outpatients / psychology*
  • Pregnancy
  • Software*
  • Time Factors
  • Young Adult

Substances

  • Analgesics, Opioid
  • Methadone